Dr. Moses O. ADEWUMI

Basic Information

	Name: Dr. Moses O. ADEWUMI	Faculty: BASIC MEDICAL SCIENCES
	Email: This email address is being protected from spambots. You need JavaScript enabled to view it.	Department:Virology
	Designation: Reader
Brief Biography:

`Resume`

Dr. Moses O. Adewumi's CV

CONTACT ADDRESS: DEPARTMENT OF VIROLOGY, UNIVERSITY COLLEGE HOSPITAL, UNIVERSITY OF IBADAN, IBADAN OYO STATE NIGERIA.
NAME: ADEWUMI OLUBUSUYI MOSES		POSITION TITLE: DR.
EDUCATION/TRAINING
INSTITUTION AND LOCATION	DEGREE		YEAR	FIELD OF STUDY
University of Ilorin, Ilorin, Nigeria	B.Sc.		1992	Zoology
University of Ibadan, Ibadan, Nigeria	M.Sc.		2001	Virology
University of Ibadan, Ibadan, Nigeria	Ph.D		2010	Virology

http://schema.org/Article">

PREVIOUS APPOINTMENTS:

Graduate Assistant - HIV/AIDS Prevention Initiative in Nigeria (APIN) and President’s Emergency Plan for AIDS Relief (PEPFAR) Projects. Department of Virology, University of Ibadan (September, 2001 to July, 2006)

Research Assistant - WHO Polio Project, Department of Virology, University of Ibadan (May, 2000 to April, 2001).

ACADEMIC/PROFESSIONAL TRAININGS DATES

Workshop on Introductory Molecular Biology and Bioinformatics 2013

Training Workshop on Immunophenotyping 2013

Training on Biosafety and Good Laboratory Practice 2012 Training Workshop on Manuscript Writing 2011

Training Workshop on Research Methodology 2011

Training Workshop on Grant Writing 2011

Laboratory Management Training Programme 2010

Training Programme on Ethics and Management for

Organizational Productivity in Health Sectors 2009

Training Workshop in Scholarly Writing and Publications 2005

Training Workshop in HIV-1 Viral Load Assay 2003

Nigerian Association for the study of the Liver workshop 2002

Training Workshop in HIV Molecular Virology 2001

Training in Immunology 1999

National Youth Service Programme 1994

SCHOLARSHIPS, FELLOWSHIPS AND PRIZES
University of Ilorin “Undergraduate Scholarship” Awards for Academic Excellence 1989 to 1992

World Health Organization Scholarship to attend the WHO Polio Laboratory Network 4^th Meeting of Data Managers and Directors 16-21^st of October, 2000 in Lusaka, Zambia.

University of Ibadan “Postgraduate School Scholarship Awards” - 2003 to 2006

The International AIDS Society (IAS) and the Australasian Society for HIV Medicine (ASHM) Scholarship to attend the 4^th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 22-25, 2007, Sydney, Australia

Keystone Symposia Global Health Travel Award Scholarship to attend the T1 Molecular and Cellular Biology: Challenges of Global Vaccine Development (T1) symposium held between October 08 and 13, 2007 at Cape Town, South Africa
Microbicides 2008 Scholarship to participate at the Microbicides 2008 Conference, February 22-27, New Delhi, India

Keystone Symposia Global Health Travel Award Scholarship to attend the X4 HIV Immunobiology: From Infection to Immune Control held at Keystone, Colorado, USA between March 22 and 27, 2009The International AIDS Society (IAS) Scholarship Award to attend the 5^th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009) slated for July 19-22, 2009 at the Cape Town International Convention Centre (CTICC), South Africa.

Keystone Symposia Global Health Travel Award Scholarship to attend the A6 HIV Biology and Pathogenesis to be held at Santa Fe Community Convention Center, Santa Fe, New Mexico, USA on Jan 12 - Jan 17, 2010.
Volkswagen Foundation Scholarship Award to collaborate within the network "Global Young Faculty" in the planning (June 21-23, 2010) and attendance (November 02-06, 2010) of the conference titled "Our Common Future" in Hanover and Essen, Germany; as well as conferment of “Our Common Future Fellow".
The National Foundation for Infectious Diseases (NFID) Scholarship Award to participate in the Fourteenth Annual Conference on Vaccine Research held in May 16-18, 2011 at the Baltimore Marriot Waterfront Hotel in Baltimore, Maryland, USA.
Keystone Symposia Global Health Travel Award Scholarship to attend theX8, Frontiers in HIV Pathogenesis, Therapy and Eradication to be held at the Whistler Conference Centre in Whistler, British Columbia, Canada on March 26 - 31, 2012.

GRANTS

University of Ibadan Senate Research Grants July 2012 to Date

LABORATORY EXPERIENCE

(1) Serology:

Serological diagnosis of viral infection by antigen (Ag) and antibody (Ab) detection including ELISA based screening principle for detection of HBV, HCV, HIV, Rubella

Radio Immunoassay (RIA) for diagnosis of viral infections e.g. Lassa fever virus.

Haemagglutination assays for diagnosis of viral infections e.g. Measles virus

Western Blot (Immunoblot) for confirmation of ELISA reactive samples e.g. HIV.

(2) Cell Culture:

Tissue Culture for viral isolation e.g. Poliovirus, measles virus

Neutralization tests for antibody evaluation/detection

(3) Molecular Virology:

DNA/RNA Extraction

PCR and RT-PCR (viral load) for DNA and RNA viral diagnosis e.g. HIV, HCV etc

(4) Cytometry:

Cell Count Assay including CD45, CD4⁺, CD8⁺ for ARV Therapy by Coulter, Dynabeads, Flow Cytometry.

ADDITIONAL PROFESSIONAL ACTIVITIES

Katsina State Representative (as NYSC member) at National JETS Programme ’93 in Uyo, Akwa-Ibom, Nigeria

Consultant to Kaduna State for OPV Potency Monitoring during the 3^rd round of National Immunization Days (NIDs), 20-27^th of January, 2001

Molecular Virology Training Workshop (I) for HIV/AIDS Prevention Initiative in Nigeria (APIN) Project – HIV Confirmation by Western blot (Immunoblot), DNA extraction from clotted blood held at the Department of Virology, University College Hospital, Ibadan, Nigeria between 6^th and 10^th of August, 2001

Molecular Virology Training Workshop (II) DNA Extraction, Gel Electrophoresis/PCR held at the Department of Virology, University College Hospital, Ibadan, Nigeria between 26 and 30^th of November, 2001

Participant at the Training Workshop for Roche Amplicor v1.5 Technique for HIV-1 Viral Load Determination held at the National Institute of Medical Research (NIMR), Lagos, Nigeria between 5^thand 8^th of August, 2003

Participant at the Workshop for Research Students on “Guidelines for writing a Doctoral Thesis” held at the Conference Centre, University of Ibadan, Nigeria between 24^th and 25^th of February, 2004

Participant at the Workshop on “Methodology of Basic and Applied Research” held at the Conference Centre, University of Ibadan, Nigeria between November 1^stand 5^th, 2004

Facilitator at the Training Workshop on Roche Amplicor v1.5 Technique for HIV-1 DNA PCR Test, held at the Department of Virology, University College Hospital, Nigeria between 15^th and 17^th of August, 2005

Participant at the Workshop on “Scholarly Writing and Publications” held at the Conference Centre, University of Ibadan, Nigeria between November 23 and 24, 2005

Participant at the Training Workshop on “Highly Pathogenic Avian Influenza Virus Diagnosis” conducted at National Veterinary Research Institute, Vom, Nigeria from 5^th to 10^thMarch, 2006

Participant at the WHO/CDC joint Training Workshop on “Highly Pathogenic Avian Influenza Virus Diagnosis” conducted at Kenya Medical Research Institute (KEMRI), Nairobi, Kenya between 25^th and 29^th September, 2006

Participant at the Training Workshop on ‘Data Collection, Management and Analysis in Academic Research’ held at the Conference Centre, University of Ibadan, Nigeria between 23^rd and 24^th, April, 2008

Participant at the Northwestern University - International AIDS Research and Training Program (NU-IARTP) Annual Research Workshop held at the International Institute for Tropical Agriculture (IITA) Conference Centre, Ibadan, Nigeria between May 18 and 21, 2009

Member of the Editorial Board, Journal of AIDS and HIV Research (JAHR)

Participant at the Nigeria Field Epidemiology and Laboratory Management Training Programme (NFELTP) held at Asokoro Training Centre between February 15 and 19, 2010

Participant at the Medical Education Partnership Initiative Nigeria (MEPIN)/Northwestern University Grant Writing Workshop held between June 13 and 15, 2011

Participant at the Medical Education Partnership Initiative in Nigeria (MEPIN)/Northwestern University Workshop on Research Methodology held between 28^th and 30^th July 2011.

Participant at the Medical Education Partnership Initiative in Nigeria (MEPIN)/ Northwestern University Workshop on Manuscript Writing held between 1^st and 3^rd of August 2011.

Participant at the 4^th Annual Research Workshop of the Northwestern University AIDS International Training Program held at the International Institute of Agriculture Conference Centre, Ibadan Nigeria between April 23 and 25, 2012

Participant at the Centre for Infectious and Zoonotic Diseases organized Workshop on Immunophenotyping held at Department of Virology, College of Medicine, University College Hospital, Ibadan between May 20^th and 24^th, 2013.

Participant at the World Bank, STEP-B and University of Ibadan and Centre for Biotechnology and Genetic Engineering (CENBIOGEN) Workshop on Introductory Molecular Biology and Bioinformatics held at Institute for Advanced Medical Research and Training (IAMRAT), College of Medicine, University College Hospital, Ibadan between June 16^th and 20^th, 2013.

INTERNATIONAL CONFERENCES AND MEETINGS ATTENDED

Member of 3-man Delegate at the WHO Polio Laboratory Network 4^th Meeting of Data Managers and Directors 16-21^st of October, 2000, Lusaka, Zambia

Participant at the 7^th Annual Scientific Meeting and Workshop of the Nigerian Association for the Study of the Liver (NASL), February 28^th to March 2^nd, 2002

Participant at the 4^th National Conference on HIV & AIDS, Abuja, Nigeria, 3^rd to 6^th May, 2004.

Participant at the 14^th International Conference on HIV/AIDS and Sexually Transmitted Infections in Africa, Abuja, Nigeria 5^th to 9^th December, 2005

Participant at the Keystone Symposium on Molecular and Cellular Biology: Challenges of Global Vaccine Development (T1), Oct 08 - 13, 2007, Cape Town, South Africa

Participant at the Microbicides 2008 Conference, February 22-27, 2008 New Delhi, India.

Participant at the Keystone Symposium on HIV Immunobiology: From Infection to Immune Control (X4) held at Keystone, Colorado, USA between March 22 and 27, 2009

Participant at the 5^th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009) held at the Cape Town International Convention Centre (CTICC), South Africa between July 19 and 22, 2009.

Participant at the Keystone Symposium on HIV Biology and Pathogenesis (A6) held at Santa Fe Convention Center, Santa Fe, New Mexico, USA between January 12 and 17, 2010

Participant at the Joint Mid-Term Meeting of the "Global Young Faculty" to plan for the forthcoming conference titled "Our Common Future 2010" in Essen, Germany between June 21 and 23, 2010.

Participant at the international conference titled "Our Common Future 2010" in Hanover and Essen, Germany between November 2 and 6, 2010.

Participant at the National Foundation for Infectious Diseases (NFID) organized Fourteenth Annual Conference on Vaccine Research held at the Baltimore Marriot Waterfront Hotel in Baltimore, Maryland, USA between May 16 and 18, 2011.

Participant at the Keystone Symposium titled ‘Frontiers in HIV Pathogenesis, Therapy and Eradication (X8)’ held at the Whistler Conference Centre, Whistler, British Columbia, Canada between March 26 and 31, 2012.

MEMBERSHIP OF PROFESSIONAL SOCIETIES

International AIDS Society (IAS)

American Society of Microbiology (ASM)

International Society for Infectious Diseases (ISID)

Researches

Contributions to Science

HIV and AIDS

Earliest cases of HIV in Nigeria were reported in 1985. By 2001 HIV prevalence had increased to a highest 5.8%. Lack of prompt and effective HIV diagnosis among other factors were implicated in the unabated spread. As a doctoral degree student in 2001, I became part of the US funded AIDS Prevention Initiative Program in Nigeria (APIN) team and worked both as a Counsellor and Phlebotomist on the field and Scientist for laboratory analysis of various samples. We evaluated varied HIV diagnostic test kits imported to the country to ascertain reliability of test results, and subsequently highlighted the impacts of inaccurate testing on spread of HIV in Nigeria. Our work helped in fashioning an effective HIV testing algorithm for the country. In Nigeria with a population of about 160 million, the seemly low (in comparison to other developing countries) prevalence rate of 5.8% translated to a third highest in the number of HIV infected individuals globally. Consequently, availability and affordability of branded antiretroviral therapy (ART) became a challenge. In response to the challenge, I monitored HIV infected individuals on generic highly active antiretroviral therapy (HAART) using plasma viral load and CD4 T-cell levels over a period of at least twenty-four months. The study was carried out to help ascertain virologic and immunologic responses and effectiveness of available generic HAART. Outcome of the study helped in the upward review of baseline CD4 for ART initiation, and administration of generic HAART to overwhelming population of HIV infected individuals in the country. In the course of the study, it was noted that significant proportion of the patients presented late to the hospital, and often with opportunistic infections (OIs) like cryptoccocal meningitis. Consequently, a number of the patients had suspected HIV-associated neurological infections. In response to these observations, the ongoing research works in UNC, Chapel Hill and Harvard, Boston were developed to define possible contributions of HIV compartmentalization in the central nervous system (CNS) to the observed disease condition. The studies aimed to ascertain viral diversity and CNS compartmentalization in non-B HIV-1 and HIV-1 and 2 infected patients from Nigeria and Mali respectively.

Hepatitis B Virus

Hepatitis B virus (HBV) infection remained a public health challenge in Nigeria, and lack of effective diagnostic and intervention schemes were identified as major factors for its spread. My early work as independent researcher on determination of prevalence of HBV among HIV naïve and infected population confirmed endemicity and comparable rates of HBV infection independent of HIV-status in Nigeria. Consequent to the outcome of the study, it was recommended that prevention measures including access to prompt and appropriate diagnosis of HBV should be promoted regardless of HIV status in the population. Also, consequent to the findings a team of researchers was formed to collaborate with the aim of studying epidemiology and the ‘evolutionary dynamics of hepatitis in Nigeria’ (EDHIN). Our first study involved evaluation of HBV diagnostic parameters among over one thousand participants from varied populations to confirm endemicity and isolate circulating strains of the virus in the country. We reported HBV Immune Escape Mutant (IEM) for the first time in Nigeria. The first documented case was from a pregnant woman, and subsequently we isolated similar strains from apparently healthy community dwellers. We highlighted consequences of breakthrough infections by IEMs in vaccinated population and the spread of the mutant HBV variants in the country at large.

Enteroviruses

Nigeria was one of the few countries with uninterrupted wild poliovirus transmission after the year 2000 global target for polio eradication. Endemicity and unabated wild polio transmission in the country was in contrast to huge investments on expanded program on immunization (EPI) by the government and foreign partners, and statement of success reported in vaccine coverage by the Federal Ministry of Health (FMoH). It was an opportunity for me as a graduate student to investigate and verify the claimed success in vaccination program. Immunity to poliovirus serotypes was evaluated among children in Southwestern region of Nigeria, and subsequently in other regions alongside some colleagues. Our studies confirmed low herd immunity to poliovirus in the population, and subsequently recommended re-evaluation and monitoring of vaccination procedure, especially in the hard-to-reach areas in the country. During the end phase of global poliovirus eradication, I participated as a Consultant in the WHO funded poliovirus laboratory containment program in Nigeria. With poliovirus in control globally, attentions have been drawn to other enteroviruses of clinical importance. In response to this, I have been in collaboration with colleagues, and together we have evaluated the WHO diagnostic algorithms for poliovirus isolation and identification, and its implications on the perception of enterovirus diversity in the region. As a Visiting Scholar in UNC, Chapel Hill, a collaborative study was initiated with my host to develop deep sequencing-based protocol for isolation and identification of enteroviruses. When completed the protocol will help improve enteroviruses investigation in Nigeria and globally.

Publications

PUBLICATIONS

A. Thesis and Dissertation

Some Aspects of the Biology of Rastrococcus sp. (Homoptera: Pseudococcidae) infesting Acalypha sp. – November, 1992
Antibodies to Poliovirus types 1, 2 and 3 in Children in Oyo and Ogun States, Nigeria – September, 2001
Human T₄-Lymphocyte and Plasma HIV-1 RNA Changes among Infected Individuals on Generic Highly Active Antiretroviral Therapy in Nigeria – June, 2010

B. Journal Articles

1. Opaleye O.O., Adewumi M.O., Donbraye E., Bakarey A.S., Odaibo G.N., Olaleye D.O. Prevalence of Measles Neutralizing Antibody in Children under 15 years in southwestern Nigeria. Afr. J. Clin. Exper. Microbiol.2005; 6(1):60-63

2. Adewumi, M.O., Donbraye, E., Odaibo, G.N., Bakarey, A.S., Opaleye, O.O. and Olaleye, D.O. Neutralizing Antibodies against poliovirus serotypes among children in southwestern Nigeria. Journal of Tropical Paediatrics. 2006; 52(2):92-95.

3. Odaibo, G.N., Donbraye, E., Adewumi, M.O., Bakarey, A.S., Ibeh M.A. and Olaleye, D.O. Reliability of testing and potential impact on HIV prevention in Nigeria. African Journal of Medicine and Medical Sciences. 2006;35, Suppl. 131-135

4. Sule W.F., Adewumi M.O. and Samuel T.C. (2009). Human immunodeficiency virus (HIV) specific antibodies among married pregnant women and female commercial sex workers attending voluntary counseling and HIV testing (VCT) centre in Abuja, Nigeria. African Journal of Biotechnology Vol. 8 (6), pp. 941-948, 20 March, 2009

5. W.F. Sule, S. C. Enemuor, M. O. Adewumi and O. C. Attah (2009). Traditional crop farmers in Kogi East, Nigeria elucidate elevated HIV and AIDS prevalence level during a five-year study period. African Journal of Microbiology Research Vol. 3(4) pp. 128-132 April, 2009

6. Donbraye, E., Adewumi, M.O., Odaibo, G.N., Bakarey, A.S., Opaleye, O. O. and Olaleye, D.O. Evaluation of Immunity against poliovirus serotypes among children in riverine areas of Delta State, Nigeria. Afr. J. Clin. Exper. Microbiol. Vol. 12(2) pp72-75 May, 2011.

7. Adaramoye O.A., Adesanoye O.A., Adewumi O.M., Akanni O., Studies on the toxicological effect of nevirapine, an antiretroviral drug on the liver, kidney and testis of male Wistar rats. Hum Exp Toxicol. 2012 Jul;31(7):676-85. Epub 2011 Oct 25.

8. Adaramoye O.A., Adewumi O.M., Adesanoye O.A., Faokunla O.O. and Farombi E.O. Effect of tenofovir, an antiretroviral drug, on hepatic and renal functional indices of Wistar rats: protective role of vitamin E. J Basic Clin Physiol Pharmacol. 2012 Apr 26; 23 (2):69-75. doi: 10.1515/jbcpp.2011.0042.

9. Japhet M.O., Adesina O.A., Donbraye E., Adewumi M.O., Hepatitis B Core IgM Antibody (anti-HBcIgM) Among Hepatitis B Surface Antigen (HBsAg) Negative Blood Donors in Nigeria. Virology Journal 8:513 doi:10.1186/1743-422X-8-513

10. W.F. Sule, A.T. Kajogbola, M.O. Adewumi (2013) High Prevalence of Anti-Hepatitis A Virus Immunoglobulin G antibody among Healthcare Facility Attedees in Osogbo, Nigeria. Journal of Immunoassay and Immunochemistry 34:1, 75-82 http://dx.doi.org/10.1080/15321819.2012.683502

11. Adewumi M.O., Olusanya R.B., Oladunjoye B.A. and Adeniji J.A. (2013) Qualitative and Quantitative Analysis of Rubella IgG Antibody among Pregnant Women in Ibadan, Nigeria. Afr. J. Clin. Exper. Microbiol 14(1): 40-44 http://dx.doi.org/10.4314/ajcem.v14i1.9

12. Adeniji J.A., Onoja A.B., Adewumi M.O. (2014) Poliovirus neutralization antibody dynamics among children in a north central and south-western Nigeria states J Immunoassay Immunochem. PMID: 24568629 Feb 25, 2014. [Epub ahead of print]

13. Adegboye O.A., Adegboye A.A, Adewumi M.O., Sule W.F (2014) Low and zero prevalence rates of anti-measles virus immunoglobulin G in mothers and their infants respectively in health centers in Osogbo, Nigeria. British Journal of Medicine and Medical Research 4(32): 5107-5115

14. Adewumi M.O., Donbraye E., Sule W.F., Olaniran O (2014) HBV infection among HIV-infected cohort and HIV-negative hospital attendees in southwestern Nigeria African Journal of Infectious Diseases 9(1): 14–17.

15. Adeniji J.A., Osundare F.A., Adewumi M.O., Onoja A.B., Fagbami A.H.(2014) Immunity to poliovirus serotypes in children population of selected communities in south-west Nigeria African Journal of Infectious Diseases (2015) 9(1): 1 – 5.

16. Abraham-O.J., Adewumi M.O., Onoja A.B., Suleiman I.,Sulaiman, L.K., Ahmed S. J. and Jagboro, S.T. (2014). Seroprevalence of Infectious Bursal Disease Virus in Local Chickens in Udu Local Government Area of Delta State, South East Nigeria (Accepted for publication in Journal of Immunoassay and Immunochemistry - July 2014)

17. Adewumi M.O., Odaibo G.N., Olaleye O.D. (2014) Efficacy of generic highly active antiretroviral therapy in HIV-1 infected individuals in Nigeria (Accepted for publication in Journal of Immunoassay and Immunochemistry).

18. Adewumi M.O., Olayinka O.A., Olusola B.A, Faleye T.O.C, Sule W.F, Adesina Olubukola (2014). Epidemiological evaluation of rubella virus infection among pregnant women in Ibadan, Nigeria (In press).

19.Faleye T.O.C., Adewumi M.O., Ifeorah I.M, Omoruyi E.C., Bakarey S.A., Akere Adegboyega, Awokunle Funmilola, Ajibola H.O., Makanjuola D.O., Adeniji J.A. (2014). Detection of hepatits B virus isolates with mutations associated with immune escape mutants in Ibadan, Southwestern Nigeria (Accepted for publication in SpringerPlus Open Journal, October, 2014).

C. Abstracts Presented at Conferences

1. Odaibo G.N., Jegede S.A., Fayemiwo S.A., Agboola A., Aina O., Adewumi M., Donbraye E., Sankale J.L., Kanki P. and Olaleye D.O. (2003): HIV-1 infection among Non-injection drug users in Ibadan, Nigeria. 13^th International Conference on AIDS and STIs in Africa. September 21^st-26^th, 2003. Abstract #368380 (Oral presentation) P.58.

2. Odaibo G.N., Sankale J.L., Jegede S.A., Ekanem E.E., Ojebode T.O., Aina O., Adewumi M., Donbraye E., Ajuwon J.A., Orubuloye I.O., Kanki P. and Olaleye D.O. (2003): Community-based Survey of HIV Infection in Oyo State, Nigeria. 13^th International Conference on AIDS and STIs in Africa. September 21^st-26^th, 2003. Abstract #446844 (Oral presentation) P.183.

3. Olaleye D.O., Sankale J.L., Odaibo G.N., Ekanem E.E., Aina O., Donbraye E., Adewumi M., Forbi J. and Kanki P. (2003): Circulating HIV-1 subtypes and recombinants in South Western Nigeria. 13^th International Conference on AIDS and STIs in Africa. September 21^st-26^th, 2003. Abstract #989353 (Poster presentation) P.294.

4. Odaibo G.N., Donbraye E., Adewumi M., Bakarey A., Ibeh M., Sankale J.L., Olaleye D.O. and Kanki P. (2006): Reliability of testing and potential impact on HIV prevention in Nigeria. 16^th International AIDS Conference 2006, August 13-18: Abstract number: MoPEO109

5. Adewumi M.O., Odaibo G.N., Donbraye E., Bakarey A.S. and Olaleye, D.O. (2008). Some immunological and virological parameters in HIV infected individuals on HAART in southwestern, Nigeria. 1^st Unibadan Conference of Biomedical Research, August, 26-29, 2008. Abstract number:B51(Oral presentation) P.77

6. Adewumi M.O., Olusanya R.B., Oladunjoye B.A., Adeniji J.A. (2011) Qualitative and Quantitative Analysis of Rubella IgG antibody among Pregnant Women in Ibadan, Nigeria. Fourteenth Annual Conference on Vaccine Research in Baltimore, Maryland, USA between May 16 and 18, 2011. Abstract number: TG10 (Poster presentation) P.101

7. Adewumi M.O., Donbraye E., Sule W.F., Olaniran O., (2012) Hepatitis B surfaceAntigenemia among HIV Cohort and other Hospital Attendees in Southwestern Nigeria. Keystone Symposium titled ‘Frontiers in HIV Pathogenesis, Therapy and Eradication’ Whistler Conference Centre, Whistler, British Columbia, Canada between March 26 and 31, 2012. Abstract number: X8 139 (Poster presentation) P.162

Contact Information

Phone: 08060226655	Address:	Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Facebook: Profile Link	LinkedIn: Profile Link	Twitter: Profile Link
Instagram: Profile Link	YouTube: Profile Link	Pinterest: Profile Link

Dr. Moses O. ADEWUMI

Basic Information

`Resume`

Researches

Publications

Contact Information

NEW YEAR MESSAGE FROM THE GLOBAL SPONSOR A STUDENT PROGRAMME (G-SASP) BOARD

Celebrating the 9th Provost of CoMUI Prof. Olusegun O. Akinyinka @ 70

COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN (CoMUI) CELEBRATES THREE NEW FELLOWS OF THE NIGERIAN ACADEMY OF SCIENCE

COMUI HOLDS WORKSHOP FOR CORE ADMINISRATORS AND SECRETARIES

COMUI Provost’s End-of-Year/New-Year Message

Official Handover of Report Documents from the Immediate Past Provost, Professor Olayinka Omigbodun, FAS

CoMUI INDUCTS BACHELOR OF MEDICAL LABORATORY SCIENCE (BMLS) GRADUATING CLASS OF 2024

VALEDICTORY PROGRAMME & LECTURE IN HONOR OF PROFESSOR ADERONKE O. AKINPELU

CoMUI HOLDS COMMUNITY ENGAGEMENT WITH THE NEW UNIVERSITY OF IBADAN PRO-CHANCELLOR

APPRECIATION FOR BENEFACTION

Quick Links

Get In Touch

Dr. Moses O. ADEWUMI

Quick Links

Social Links

Get In Touch